Stock Analysis

Vice President of Human Resources Elizabeth Phillips Sold A Bunch Of Shares In Kewaunee Scientific

Anyone interested in Kewaunee Scientific Corporation (NASDAQ:KEQU) should probably be aware that the Vice President of Human Resources, Elizabeth Phillips, recently divested US$297k worth of shares in the company, at an average price of US$43.20 each. The eyebrow raising move amounted to a reduction of 45% in their holding.

Advertisement

The Last 12 Months Of Insider Transactions At Kewaunee Scientific

The insider, Anita Zucker, made the biggest insider sale in the last 12 months. That single transaction was for US$2.6m worth of shares at a price of US$63.96 each. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. It's of some comfort that this sale was conducted at a price well above the current share price, which is US$43.90. So it may not tell us anything about how insiders feel about the current share price.

Over the last year we saw more insider selling of Kewaunee Scientific shares, than buying. They sold for an average price of about US$56.56. It is certainly not great to see that insiders have sold shares in the company. But we note that the selling, on average, was at well above the recently traded price of US$43.90. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

See our latest analysis for Kewaunee Scientific

insider-trading-volume
NasdaqGM:KEQU Insider Trading Volume October 8th 2025

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar).

Does Kewaunee Scientific Boast High Insider Ownership?

For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Insiders own 25% of Kewaunee Scientific shares, worth about US$31m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

So What Does This Data Suggest About Kewaunee Scientific Insiders?

Insiders haven't bought Kewaunee Scientific stock in the last three months, but there was some selling. And our longer term analysis of insider transactions didn't bring confidence, either. Insiders own shares, but we're still pretty cautious, given the history of sales. We're in no rush to buy! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Kewaunee Scientific. You'd be interested to know, that we found 3 warning signs for Kewaunee Scientific and we suggest you have a look.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Valuation is complex, but we're here to simplify it.

Discover if Kewaunee Scientific might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.